What has been the impact of the Index today?

Already we have began to see the impact of the Index as companies, that have embraced the Index, have began to use it as a tool for broadening CRS programs into greater business strategies.

In addition, it is our goal that the Index becomes:
• A tool to assist companies develop, implement and measure the direction of their access to medicine programs
• A way for companies to benchmark and share best practices within and across sectors
• For articulating, clarifying, and uniting the dialogue around ‘access’ issue with internal and external stakeholders from institutional investors to nonprofits.
• Positively stimulates investments in access to medicine programs of large pharmaceutical companies.